Professor David Kisor saw a need for more pharmacogenomic education for pharmacists, and he wanted to fill it. Dr. Kisor, PharmD, serves as professor and chair of pharmaceutical sciences at…
Read More
Imagine not being able to pick up a pencil without your fingers hurting. Sending a letter, doing a crossword puzzle, these are just a few of the simple tasks that…
Read More
A young woman’s treatment with a common prescription painkiller for her chronic bladder pain eventually landed her in the emergency room. The 24 year old had started taking the…
Read More
People regularly taking a common type of painkiller called an NSAID may be at greater risk for heart attack or stroke than previously thought. The U.S. Food and Drug Administration…
Read More
By John C. Nelson, MD, MPH I was pleased to read an insightful editorial discussing precision medicine in the June edition of the Journal of the American Medicine Association. There…
Read More
The top drug safety agencies in the U.S. and Europe have raised concerns about the risks associated with codeine in children’s cold-and-cough medicine. This month, the U.S. Food and…
Read More
The evidence for expanded use of pharmacogenetic data to help inform heart medication prescribing just got stronger. A comprehensive review of the scientific literature on pharmacogenomics and heart medications found…
Read More
The mental deterioration of a 33-year-old man with HIV began with vivid dreams just weeks after he began a standard course of HIV treatment. The treatment was a combination of…
Read More
As a 12 year-old-boy in India, Ranjit Thirumaran, M.Pharm, PhD, saw the toll adverse drug reactions can take firsthand. Following hospitalization after a minor accident, his uncle suddenly died, likely…
Read More
Update: The results of this research are in! Find out more here. How can pharmacogenetic testing improve care for elderly patients taking multiple medications? Genelex is trying to find out.…
Read More
